First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping researchers promote themselves alongside their papers. Zongwang Zhang is first author on ‘ A DUSP6 inhibitor suppresses inflammatory cardiac remodeling and improves heart function after myocardial infarction’, published in DMM. Zongwang is a PhD student in the lab of Jing-Wei Xiong at Peking University, Beijing, China, investigating therapeutic targets and drugs for cardiovascular diseases.
{"title":"First person – Zongwang Zhang","authors":"","doi":"10.1242/dmm.050003","DOIUrl":"https://doi.org/10.1242/dmm.050003","url":null,"abstract":"\u0000 First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping researchers promote themselves alongside their papers. Zongwang Zhang is first author on ‘ A DUSP6 inhibitor suppresses inflammatory cardiac remodeling and improves heart function after myocardial infarction’, published in DMM. Zongwang is a PhD student in the lab of Jing-Wei Xiong at Peking University, Beijing, China, investigating therapeutic targets and drugs for cardiovascular diseases.","PeriodicalId":141347,"journal":{"name":"Disease Models & Mechanisms","volume":"50 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116812051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Pulling back the curtain: live imaging adult disease processes","authors":"K. Kwan","doi":"10.1242/dmm.050027","DOIUrl":"https://doi.org/10.1242/dmm.050027","url":null,"abstract":"","PeriodicalId":141347,"journal":{"name":"Disease Models & Mechanisms","volume":"69 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125530808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping researchers promote themselves alongside their papers. Arnaud Duchon is first author on ‘ Ts66Yah, a mouse model of Down syndrome with improved construct and face validity’, published in DMM. Arnaud is a PhD research engineer in the lab of Yann Herault at the Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Illkirch-Graffenstaden, France, investigating trisomy 21 (Down syndrome) with mouse model approaches.
{"title":"First person – Arnaud Duchon","authors":"","doi":"10.1242/dmm.049964","DOIUrl":"https://doi.org/10.1242/dmm.049964","url":null,"abstract":"\u0000 First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping researchers promote themselves alongside their papers. Arnaud Duchon is first author on ‘ Ts66Yah, a mouse model of Down syndrome with improved construct and face validity’, published in DMM. Arnaud is a PhD research engineer in the lab of Yann Herault at the Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Illkirch-Graffenstaden, France, investigating trisomy 21 (Down syndrome) with mouse model approaches.","PeriodicalId":141347,"journal":{"name":"Disease Models & Mechanisms","volume":"54 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123318713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping researchers promote themselves alongside their papers. Emily Warren is first author on ‘ 17q12 deletion syndrome mouse model shows defects in craniofacial, brain and kidney development, and glucose homeostasis’, published in DMM. Emily conducted the research described in this article while a postdoctoral fellow in Eric M. Morrow's lab at Brown University, Providence, RI, USA. She is now a postdoctoral fellow in the lab of Peter J. McGuire at the National Institutes of Health (NIH) National Human Genome Research Institute (NHGRI), Bethesda, MD, USA, investigating how metabolic dysfunction impacts the brain, particularly in the context of neurodevelopment and neurodegeneration.
《第一人称》是对发表在《疾病模型与机制》上的论文的第一作者的一系列采访，帮助研究人员在论文的同时提升自己。Emily Warren是《17q12缺失综合征小鼠模型显示颅面、大脑和肾脏发育缺陷以及葡萄糖稳态》的第一作者，发表于《DMM》杂志。艾米丽在美国普罗维登斯布朗大学埃里克·m·莫罗实验室做博士后时进行了本文中描述的研究。她现在是美国国立卫生研究院(NIH)国家人类基因组研究所(NHGRI) Peter J. McGuire实验室的博士后，研究代谢功能障碍如何影响大脑，特别是在神经发育和神经变性的背景下。
{"title":"First person – Emily Warren","authors":"","doi":"10.1242/dmm.050017","DOIUrl":"https://doi.org/10.1242/dmm.050017","url":null,"abstract":"\u0000 First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping researchers promote themselves alongside their papers. Emily Warren is first author on ‘ 17q12 deletion syndrome mouse model shows defects in craniofacial, brain and kidney development, and glucose homeostasis’, published in DMM. Emily conducted the research described in this article while a postdoctoral fellow in Eric M. Morrow's lab at Brown University, Providence, RI, USA. She is now a postdoctoral fellow in the lab of Peter J. McGuire at the National Institutes of Health (NIH) National Human Genome Research Institute (NHGRI), Bethesda, MD, USA, investigating how metabolic dysfunction impacts the brain, particularly in the context of neurodevelopment and neurodegeneration.","PeriodicalId":141347,"journal":{"name":"Disease Models & Mechanisms","volume":"3 4 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114374882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"COVID-19's next top model","authors":"Kirsty M Hooper","doi":"10.1242/dmm.049972","DOIUrl":"https://doi.org/10.1242/dmm.049972","url":null,"abstract":"","PeriodicalId":141347,"journal":{"name":"Disease Models & Mechanisms","volume":"21 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122346243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping researchers promote themselves alongside their papers. Xiao Li is first author on ‘ Cdk8 attenuates lipogenesis by inhibiting SREBP-dependent transcription in Drosophila’, published in DMM. Xiao conducted the research described in this article while a graduate student in Jun-yuan Ji's lab at Texas A&M University Health Science Center, College Station, TX, USA. He is now a postdoctoral fellow in the lab of Michael Levine at Princeton University, Princeton, NJ, USA, investigating the mechanisms of transcription regulation.
{"title":"First person – Xiao Li","authors":"","doi":"10.1242/dmm.049968","DOIUrl":"https://doi.org/10.1242/dmm.049968","url":null,"abstract":"\u0000 First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping researchers promote themselves alongside their papers. Xiao Li is first author on ‘ Cdk8 attenuates lipogenesis by inhibiting SREBP-dependent transcription in Drosophila’, published in DMM. Xiao conducted the research described in this article while a graduate student in Jun-yuan Ji's lab at Texas A&M University Health Science Center, College Station, TX, USA. He is now a postdoctoral fellow in the lab of Michael Levine at Princeton University, Princeton, NJ, USA, investigating the mechanisms of transcription regulation.","PeriodicalId":141347,"journal":{"name":"Disease Models & Mechanisms","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133936802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping researchers promote themselves alongside their papers. Payel Kundu is first author on ‘ Xanthohumol improves cognition in farnesoid X receptor-deficient mice on a high-fat diet’, published in DMM. Payel conducted the research described in this article while a postdoctoral fellow in Jacob Raber's lab at Oregon Health and Science University, Portland, OR, USA. She is now a health scientist in the lab of Sharlee More at Cardno ChemRisk, Aliso Viejo, CA, USA, intervening on metabolism to promote healthy cognitive ageing and reduce the detrimental effects of consumption of a Western diet.
{"title":"First person – Payel Kundu","authors":"","doi":"10.1242/dmm.049983","DOIUrl":"https://doi.org/10.1242/dmm.049983","url":null,"abstract":"\u0000 First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping researchers promote themselves alongside their papers. Payel Kundu is first author on ‘ Xanthohumol improves cognition in farnesoid X receptor-deficient mice on a high-fat diet’, published in DMM. Payel conducted the research described in this article while a postdoctoral fellow in Jacob Raber's lab at Oregon Health and Science University, Portland, OR, USA. She is now a health scientist in the lab of Sharlee More at Cardno ChemRisk, Aliso Viejo, CA, USA, intervening on metabolism to promote healthy cognitive ageing and reduce the detrimental effects of consumption of a Western diet.","PeriodicalId":141347,"journal":{"name":"Disease Models & Mechanisms","volume":"31 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116210526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Reducing the shock factor with new anti-epilepsy drugs","authors":"K. Hooper","doi":"10.1242/dmm.049886","DOIUrl":"https://doi.org/10.1242/dmm.049886","url":null,"abstract":"","PeriodicalId":141347,"journal":{"name":"Disease Models & Mechanisms","volume":"26 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125011465","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping researchers promote themselves alongside their papers. Sai Pradhan is first author on ‘ Integrated multi-omics analysis of Huntington disease identifies pathways that modulate protein aggregation’, published in DMM. Sai Sanwid is a PhD Student in the lab of Venketesh Sivaramakrishnan at the Sri Sathya Sai Institute of Higher Learning, Prasanthi Nilayam, Anantapur, India, investigating neurodegenerative diseases, like Huntington disease, which are caused by protein aggregation. His research interest is focused on understanding the mechanisms associated with disease progression and identifying potential biomarkers associated with progression and prognosis, as well as therapeutic targets and agents that confer neuroprotection for better management of the disease.
{"title":"First person – Sai Sanwid Pradhan","authors":"","doi":"10.1242/dmm.049895","DOIUrl":"https://doi.org/10.1242/dmm.049895","url":null,"abstract":"\u0000 First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping researchers promote themselves alongside their papers. Sai Pradhan is first author on ‘ Integrated multi-omics analysis of Huntington disease identifies pathways that modulate protein aggregation’, published in DMM. Sai Sanwid is a PhD Student in the lab of Venketesh Sivaramakrishnan at the Sri Sathya Sai Institute of Higher Learning, Prasanthi Nilayam, Anantapur, India, investigating neurodegenerative diseases, like Huntington disease, which are caused by protein aggregation. His research interest is focused on understanding the mechanisms associated with disease progression and identifying potential biomarkers associated with progression and prognosis, as well as therapeutic targets and agents that confer neuroprotection for better management of the disease.","PeriodicalId":141347,"journal":{"name":"Disease Models & Mechanisms","volume":"36 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131694163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：